Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biofrontera AG (GB:0DOL)
LSE:0DOL
Holding GB:0DOL?
Track your performance easily
0DOL Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€14.30 - €14.30
Previous Close€14.3
Volume0.00
Average Volume (3M)N/A
Market Cap
€16.41M
Enterprise Value€13.60M
Total Cash (Recent Filing)€4.38M
Total Debt (Recent Filing)€1.44M
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding63,807,058
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.20
R-Squared0.05
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)6.16
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
0DOL FAQ
What was Biofrontera AG’s price range in the past 12 months?
Biofrontera AG lowest share price was €14.30 and its highest was €14.30 in the past 12 months.
What is Biofrontera AG’s market cap?
Currently, no data Available
When is Biofrontera AG’s upcoming earnings report date?
Biofrontera AG’s upcoming earnings report date is Apr 24, 2025 which is in 148 days.
How were Biofrontera AG’s earnings last quarter?
Currently, no data Available
Is Biofrontera AG overvalued?
According to Wall Street analysts Biofrontera AG’s price is currently Overvalued.
Does Biofrontera AG pay dividends?
Biofrontera AG does not currently pay dividends.
What is Biofrontera AG’s EPS estimate?
Biofrontera AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biofrontera AG have?
Biofrontera AG has 6,076,862 shares outstanding.
What happened to Biofrontera AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biofrontera AG?
Currently, no hedge funds are holding shares in GB:0DOL
---
Biofrontera Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-14.71%
Trailing 12-Months
Asset Growth
-12.31%
Trailing 12-Months
Company Description
Biofrontera AG
Biofrontera AG is active in the field of healthcare in the United Kingdom. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.
---
Technical Analysis
---